Tech Company Financing Transactions
Efficas Funding Round
Efficas secured a $500 thousand venture capital round on 12/31/2009. Investors included Burrill & Company.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Burrill & Company (Joerg Riesmeier)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
310 N Harbor Blvd. 205
Fullerton, CA 92832
USA
Fullerton, CA 92832
USA
Phone
Website
Email Address
Overview
Efficas is a consumer focused health-science and technology company committed to developing effective products for the nutritional management of the immune system for both humans and pets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Braman
VP - Operations
Robert Driver
Browse more venture capital transactions:
Prev: 12/31/2009: SeeWhy venture capital transaction
Next: 12/31/2009: C3 Energy venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs